Related Experiment Videos
Tuberous sclerosis--another success for magnetic resonance imaging
1Department of Neuropathology, Massachusetts General Hospital, Boston 02114.
Mayo Clinic Proceedings
|March 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Vascular Access Questionnaire: assessing patient-reported views of vascular access.
The journal of vascular access·2008
Home care assistance and the utilization of peritoneal dialysis.
Kidney international·2007
Clinical, neuropathological and genetic aspects of the tuberous sclerosis complex.
Brain pathology (Zurich, Switzerland)·1995
An improved approach to prepare human brains for research.
Journal of neuropathology and experimental neurology·1995
The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system.
Brain pathology (Zurich, Switzerland)·1995
Topical Therapy for the Internist: A Practical Framework for Safer Prescribing.
Mayo Clinic proceedings·2026
Treatment of Parkinson Disease.
Mayo Clinic proceedings·2026
Navigating Protein-Losing Enteropathy: A Stepwise Approach for Primary Care Clinicians.
Mayo Clinic proceedings·2026
The Impact of Animal-Assisted Treatment on Inpatient Stroke Rehabilitation.
Mayo Clinic proceedings·2026
Cardiac Troponin in Autoimmune Rheumatic Diseases: Lights and Shadows.
Mayo Clinic proceedings·2026
Trojan mast cells: repurposing allergy for targeted oncolytic delivery.
Trends in pharmacological sciences·2026
Remote photobiomodulation: A systemic approach to neuroprotection.
International review of neurobiology·2026
Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin-berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026